Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DR26FHLH1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,135
Award facts
- Contract value 100% obligated
- $5,134.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $5,134.64 delivery order to DMS Pharmaceutical Group Inc. on June 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for EXPAREL 266 MG/20 ML vials.
DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is firm fixed price with an ultimate completion date of June 24, 2026. Place of performance is Park Ridge, IL.
Quick answers
Who was awarded contract SPE2DR26FHLH1?
SPE2DR26FHLH1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2026.
How much is contract SPE2DR26FHLH1 worth?
The government has obligated $5,135 on SPE2DR26FHLH1.
Is contract SPE2DR26FHLH1 an order under another contract?
Yes. SPE2DR26FHLH1 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHLH1 competed?
The extent of competition for SPE2DR26FHLH1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award